This page is part of the Potential Drug-Drug Interaction (PDDI) Clinical Decision Support (CDS) (FHIR IG) (v0.1.0: STU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v3.5.0. No current official version has been published yet. For a full list of available versions, see the Directory of published versions
{ "resourceType" : "ValueSet", "id" : "valueset-cyclosporine-exclude", "text" : { "status" : "generated", "div" : "<div xmlns="http://www.w3.org/1999/xhtml"><h2>Exclude cyclosporine Medications Value Set</h2><div><p>ValueSet containing drug identifiers to exclude. Criteria is explicitly stating ophthalmic formulations.</p> </div><p><b>Copyright Statement:</b> Attribution CC BY</p><p>This value set includes codes from the following code systems:</p><ul><li>Include these codes as defined in <a href="http://www.nlm.nih.gov/research/umls/rxnorm"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>1093178</td><td>Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune]</td><td/></tr><tr><td>402092</td><td>Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]</td><td/></tr><tr><td>1093177</td><td>Cyclosporine Ophthalmic Ointment [Optimmune]</td><td/></tr><tr><td>402330</td><td>Cyclosporine Ophthalmic Suspension [Restasis]</td><td/></tr><tr><td>1093174</td><td>Cyclosporine 0.002 MG/MG Ophthalmic Ointment</td><td/></tr><tr><td>351291</td><td>Cyclosporine 0.5 MG/ML Ophthalmic Suspension</td><td/></tr><tr><td>1093173</td><td>Cyclosporine Ophthalmic Ointment</td><td/></tr><tr><td>378766</td><td>Cyclosporine Ophthalmic Suspension</td><td/></tr><tr><td>1156187</td><td>Cyclosporine Ophthalmic Product</td><td/></tr><tr><td>1182342</td><td>Optimmune Ophthalmic Product</td><td/></tr><tr><td>1182527</td><td>Restasis Ophthalmic Product</td><td/></tr></table></li></ul></div>" }, "url" : "http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cyclosporine-exclude", "version" : "0.1.0", "name" : "valueset-cyclosporine-exclude", "title" : "Exclude cyclosporine Medications Value Set", "status" : "draft", "date" : "2018-07-02", "publisher" : "PDDI CDS", "contact" : [ { "name" : "Richard Boyce boycerd@upmc.edu" } ], "description" : "ValueSet containing drug identifiers to exclude. Criteria is explicitly stating ophthalmic formulations.", "jurisdiction" : [ { "coding" : [ { "system" : "urn:iso:std:iso:3166", "code" : "International" } ] } ], "purpose" : "To refine valueset for Digoxin + Cyclosporine PDDI-CDS", "copyright" : "Attribution CC BY", "compose" : { "include" : [ { "system" : "http://www.nlm.nih.gov/research/umls/rxnorm", "version" : "02-Jul-2018", "concept" : [ { "code" : "1093178", "display" : "Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune]" }, { "code" : "402092", "display" : "Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]" }, { "code" : "1093177", "display" : "Cyclosporine Ophthalmic Ointment [Optimmune]" }, { "code" : "402330", "display" : "Cyclosporine Ophthalmic Suspension [Restasis]" }, { "code" : "1093174", "display" : "Cyclosporine 0.002 MG/MG Ophthalmic Ointment" }, { "code" : "351291", "display" : "Cyclosporine 0.5 MG/ML Ophthalmic Suspension" }, { "code" : "1093173", "display" : "Cyclosporine Ophthalmic Ointment" }, { "code" : "378766", "display" : "Cyclosporine Ophthalmic Suspension" }, { "code" : "1156187", "display" : "Cyclosporine Ophthalmic Product" }, { "code" : "1182342", "display" : "Optimmune Ophthalmic Product" }, { "code" : "1182527", "display" : "Restasis Ophthalmic Product" } ] } ] } }